ALURW · Allurion Technologies, Inc. · Executive Compensation
$0.00
+0.00 (+0.00%)
At close · Oct 13
Return incl. dividend (before tax)
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the amount and timing of such financings are uncertain, the Company has concluded that management’s plans do not alleviate substantial doubt about its ability to continue as a going concern for a reasonable period of time.”View the 10-Q filed May 15, 2026
Market Cap
$2.01M
Shares
1.00M
Volume · Oct 13
9306
Avg daily vol (19 sessions)
40.39K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Dr. Shantanu Gaur | Chief Executive Officer | $2,829,734 |
| Brendan Gibbons | Chief Legal and People Officer | $1,097,663 |
| Ojas Buch | Chief Operating Officer | $989,714 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Benoit Chardon | Former Chief Commercial Officer | $861,517 |
| Dr. Shantanu Gaur | Chief Executive Officer | $661,226 |
| Christopher Geberth | Chief Financial Officer | $542,592 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Dr. Shantanu Gaur | Chief Executive Officer | $2,989,765 |
| Christopher Geberth | Chief Financial Officer | $1,253,457 |
| Benoit Chardon | Former Chief Commercial Officer | $658,992 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Michael Davin | Class III member of the Board | Resigned | 2026-08-24 |
| Krishna Gupta | Class I member of the board of directors | Resigned | 2026-08-24 |
| Shantanu K. Gaur, M.D. | member of the Company's board of directors | Resigned | 2026-07-23 |
| Shantanu K. Gaur, M.D. | Chief Executive Officer | Resigned | 2026-07-23 |
| Douglas Hudson | Class II member of the board of directors | Resigned | 2026-07-07 |
| R. Jason Richey | chairperson of the Audit Committee of the Board | Resigned | 2026-06-30 |
| R. Jason Richey | Class II member of the board of directors | Resigned | 2026-06-30 |
| Milena Alberti-Perez | chairperson of the Audit Committee | Resigned | 2025-10-03 |
| Milena Alberti-Perez | Class III member of the board of directors | Resigned | 2025-10-03 |
| R. Jason Richey | Class II director | Appointed | 2025-01-06 |
| Christopher Geberth | Chief Financial Officer | Resigned | 2024-11-13 |
| Keith Johns | Class III director | Appointed | 2024-09-04 |
| Milena Alberti-Perez | Class III director | Appointed | 2024-03-15 |
| Benoit Chardon | Chief Commercial Officer | Resigned | 2023-12-15 |
| Chris Geberth | Chief Financial Officer | Appointed | 2023-08-07 |
| Benoit Chardon | Managing Director of Allurion France | Appointed | 2023-08-07 |
| Ram Chuttani | Chief Medical Officer | Appointed | 2023-08-07 |
| Benoit Jacques Claude Chardon | Chief Commercial Officer | Appointed | 2023-08-07 |
| Krishna Gupta | Co-Chairman of the New Allurion board of directors | Appointed | 2023-08-07 |
| Shantanu Gaur | Chief Executive Officer | Appointed | 2023-08-07 |
| Chris Geberth | Chief Financial Officer | Appointed | 2023-08-07 |
| Omar Ishrak | Co-Chairman of the New Allurion board of directors | Appointed | 2023-08-07 |
| Larson Douglas Hudson | director | Appointed | 2023-08-07 |
| Michael Davin | director | Appointed | 2023-08-07 |
| Nicholas Lewin | director | Appointed | 2023-08-07 |
Leadership
- Krishna Gupta Chairman, Board Member
- Omar Ishrak Chairman, Board Member
- Ojas Buch COO
- Shantanu Gaur Chief Accounting Officer, Board Member
- Dr. Omar Ishrak Board Member
- Keith B. Johns II Board Member
- Keith Johns Board Member
- Larson Douglas Hudson Board Member
- Michael Davin Board Member
- Milena Alberti-Perez Board Member
- Nicholas Lewin Board Member
- R. Jason Richey Board Member